Bupivacaine Hydrochloride Injection Market
Bupivacaine Hydrochloride Injection Market Forecasts to 2030 - Global Analysis By Concentration (0.25%, 0.50%, 0.75% and Other Concentrations), Volume (Small Volume (5 ML), Medium Volume (10 ML) and Large Volume (>20 ML)), Packaging, Application, End User and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $1120.21 MN |
Projected Year Value (2030) |
US $1870.27 MN |
CAGR (2023 - 2030) |
7.6% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
Asia Pacific |
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Bupivacaine Hydrochloride Injection Market is accounted for $1,120.21 million in 2023 and is expected to reach $1,870.27 million by 2030 growing at a CAGR of 7.6% during the forecast period. Bupivacaine Hydrochloride Injection is a medication used in the field of anaesthesia and pain management. It is a local anaesthetic that is administered via injection to numb specific areas of the body. Bupivacaine works by blocking the transmission of pain signals along nerve fibers. Bupivacaine should be administered with caution, especially in high-risk patients or in situations where close monitoring is required. Bupivacaine should not be used in patients with known allergies to the drug.
According to the American Academy of Orthopedic Surgeons (AAOS) survey, over 432,000 spinal fusions are performed in the United States every year. As per the Agency for Healthcare Research and Quality, more than 790,000 knee replacements are performed yearly in the United States.
Market Dynamics:
Driver:
Rising demand for ambulatory surgical centers
ASCs are increasingly performing a wide range of surgical procedures, including orthopedic, ophthalmic, gynaecological, and dental surgeries. These centers often prefer using local anaesthetics like Bupivacaine Hydrochloride Injection for their ability to provide effective anaesthesia while allowing patients to recover quickly and go home on the same day. Also, ASCs are known for their cost-effective approach to healthcare delivery. As well as, its minimization of opioid usage, reduced risk of side effects and quick turnaround times are fuelling the market growth.
Restraint:
Stringent regulatory approval process
Regulatory authorities, such as the FDA in the United States, set high safety and efficacy standards for medications. Even after significant investment in the regulatory approval process, there is a risk of rejection or delays in approval. Even after approval, companies must comply with ongoing post-market surveillance and reporting requirements. Therefore, regulatory approval status can influence pricing and reimbursement decisions. Meeting these standards is essential but can be challenging for the market.
Opportunity:
Growing surgical procedures
Surgical procedures, whether major or minor, typically require anaesthesia to ensure patient comfort and safety during the operation. Bupivacaine Hydrochloride is a widely used local anaesthetic that provides effective pain relief during and after surgery. Bupivacaine Hydrochloride is commonly used in regional anaesthesia techniques. The rise in minimally invasive surgical procedures often involves regional anaesthesia techniques. Its applications in wide range of surgical specialties and minimally invasive procedures are propelling the market growth.
Threat:
Competition from generic versions
Generic versions of bupivacaine hydrochloride injections typically enter the market at lower prices than their branded counterparts. This can lead to price competition and erosion of profit margins for the original manufacturer. This may prompt mergers, acquisitions, or partnerships among manufacturers to achieve economies of scale and maintain profitability. It can also lead to market saturation. All these elements hinder the market demand.
Covid-19 Impact
The COVID-19 pandemic had several impacts on the pharmaceutical industry. The pandemic led to disruptions in global supply chains due to lockdowns, restrictions on transportation, and workforce shortages. This affected the availability and distribution of Bupivacaine Hydrochloride Injection. Many elective surgeries were postponed or cancelled during the peak of the pandemic to conserve resources and reduce the risk of transmission. Also, the pandemic brought attention to the importance of effective pain management in healthcare. So, there may be longer-term effects on healthcare utilization patterns, which could influence the demand for products like Bupivacaine Hydrochloride Injection.
The chronic pain management segment is expected to be the largest during the forecast period
The chronic pain management segment is estimated to have a lucrative growth. Bupivacaine Hydrochloride is often used in regional anaesthesia techniques such as epidural and nerve block procedures. It provides pain relief in specific areas of the body without causing a loss of consciousness. Compared to some other local anaesthetics, bupivacaine hydrochloride has a lower rate of systemic absorption. Its longer duration of action, preservation of muscle strength, enhanced patient comfort and satisfaction drives the segment demand.
The specialty clinics & pain management centers segment is expected to have the highest CAGR during the forecast period
The specialty clinics & pain management centers segment is anticipated to witness the highest CAGR growth during the forecast period. Bupivacaine Hydrochloride Injection is a valuable tool in the arsenal of pain management centers, offering a reliable and effective means to alleviate pain, enhance patient comfort, and support rehabilitation efforts. Bupivacaine has a longer duration of action compared to some other local anaesthetics. Due to its prolonged duration of action, bupivacaine can be especially useful in ambulatory or outpatient settings where extended pain relief is needed after a procedure.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period. The Asia-Pacific region has witnessed a rise in surgical procedures, driven by factors such as population growth, increased access to healthcare, and a rising aging population. China, India, Japan, South Korea, and Australia, have been investing significantly in their healthcare infrastructure. The adoption of advanced medical technologies and equipment has improved the quality of surgical care in the region. Further, the rising awareness of pain management and presence of strong key players are fuelling the market demand.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period. The region is well known for its technological advancements in healthcare. The aging population in North America has led to an increase in chronic pain conditions. Also, North America has a high rate of surgical procedures, including both elective and non-elective surgeries. In addition, the market for pharmaceuticals in the region is highly competitive, with both generic and brand-name manufacturers. Further, its research and development initiatives and strong market competition is boosting the North American market.
Key players in the market
Some of the key players profiled in the Bupivacaine Hydrochloride Injection Market include Hikma Pharmaceuticals, Pfizer Inc., Fresenius Kabi AG, Baxter International Inc., AstraZeneca, AuroMedics Pharma LLC, Areva, SteriMax Inc., Shanghai Harvest Pharmaceutical Co., Southwest Pharma, Hunan Kelun Pharmaceutical, Aurobindo pharma and Sagent Pharmaceuticals.
Key Developments:
In December 2021, Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, announced that it launched Bupivacaine HCl Injection, USP through its US affiliate, Hikma Pharmaceuticals USA Inc.
In July 2016, India-based pharmaceutical manufacturing company, Aurobindo pharma has got approval from the US food and drug administration (USFDA) to produce and market its anaesthetic Bupivacaine Hydrochloride injection in the American market.
Concentrations Covered:
• 0.25%
• 0.50%
• 0.75%
• Other Concentrations
Volumes Covered:
• Small Volume (5 ML)
• Medium Volume (10 ML)
• Large Volume (>20 ML)
Packagings Covered:
• Single-Dose Vials
• Multi-Dose Vials
• Ampoules
Applications Covered:
• Surgical Anaesthesia
• Obstetric Anaesthesia
• Chronic Pain Management
• Orthopedic Procedures
• Cardiovascular Procedures
• Neurological Procedures
• Dental Procedures
• Other Applications
End Users Covered:
• Ambulatory Surgical Centers (ASCs)
• Hospitals & Clinics
• Specialty Clinics & Pain Management Centers
• Dental Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bupivacaine Hydrochloride Injection Market, By Concentration
5.1 Introduction
5.2 0.25%
5.3 0.50%
5.4 0.75%
5.5 Other Concentrations
6 Global Bupivacaine Hydrochloride Injection Market, By Volume
6.1 Introduction
6.2 Small Volume (5 ML)
6.3 Medium Volume (10 ML)
6.4 Large Volume (>20 ML)
7 Global Bupivacaine Hydrochloride Injection Market, By Packaging
7.1 Introduction
7.2 Single-Dose Vials
7.3 Multi-Dose Vials
7.4 Ampoules
8 Global Bupivacaine Hydrochloride Injection Market, By Application
8.1 Introduction
8.2 Surgical Anesthesia
8.3 Obstetric Anesthesia
8.4 Chronic Pain Management
8.5 Orthopedic Procedures
8.6 Cardiovascular Procedures
8.7 Neurological Procedures
8.8 Dental Procedures
8.9 Other Applications
9 Global Bupivacaine Hydrochloride Injection Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers (ASCs)
9.3 Hospitals & Clinics
9.4 Specialty Clinics & Pain Management Centers
9.5 Dental Clinics
9.6 Other End Users
10 Global Bupivacaine Hydrochloride Injection Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Hikma Pharmaceuticals
12.2 Pfizer Inc.
12.3 Fresenius Kabi AG
12.4 Baxter International Inc.
12.5 AstraZeneca
12.6 AuroMedics Pharma LLC
12.7 Areva
12.8 SteriMax Inc.
12.9 Shanghai Harvest Pharmaceutical Co.
12.10 Southwest Pharma
12.11 Hunan Kelun Pharmaceutical
12.12 Aurobindo pharma
12.13 Sagent Pharmaceuticals
List of Tables
1 Global Bupivacaine Hydrochloride Injection Market Outlook, By Region (2021-2030) ($MN)
2 Global Bupivacaine Hydrochloride Injection Market Outlook, Concentration (2021-2030) ($MN)
3 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.25% (2021-2030) ($MN)
4 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.50% (2021-2030) ($MN)
5 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.75% (2021-2030) ($MN)
6 Global Bupivacaine Hydrochloride Injection Market Outlook, Other Concentrations (2021-2030) ($MN)
7 Global Bupivacaine Hydrochloride Injection Market Outlook, Volume (2021-2030) ($MN)
8 Global Bupivacaine Hydrochloride Injection Market Outlook, Small Volume (5 ML) (2021-2030) ($MN)
9 Global Bupivacaine Hydrochloride Injection Market Outlook, Medium Volume (10 ML) (2021-2030) ($MN)
10 Global Bupivacaine Hydrochloride Injection Market Outlook, Large Volume (>20 ML) (2021-2030) ($MN)
11 Global Bupivacaine Hydrochloride Injection Market Outlook, Packaging (2021-2030) ($MN)
12 Global Bupivacaine Hydrochloride Injection Market Outlook, Single-Dose Vials (2021-2030) ($MN)
13 Global Bupivacaine Hydrochloride Injection Market Outlook, Multi-Dose Vials (2021-2030) ($MN)
14 Global Bupivacaine Hydrochloride Injection Market Outlook, Ampoules (2021-2030) ($MN)
15 Global Bupivacaine Hydrochloride Injection Market Outlook, Application (2021-2030) ($MN)
16 Global Bupivacaine Hydrochloride Injection Market Outlook, Surgical Anesthesia (2021-2030) ($MN)
17 Global Bupivacaine Hydrochloride Injection Market Outlook, Obstetric Anesthesia (2021-2030) ($MN)
18 Global Bupivacaine Hydrochloride Injection Market Outlook, Chronic Pain Management (2021-2030) ($MN)
19 Global Bupivacaine Hydrochloride Injection Market Outlook, Orthopedic Procedures (2021-2030) ($MN)
20 Global Bupivacaine Hydrochloride Injection Market Outlook, Cardiovascular Procedures (2021-2030) ($MN)
21 Global Bupivacaine Hydrochloride Injection Market Outlook, Neurological Procedures (2021-2030) ($MN)
22 Global Bupivacaine Hydrochloride Injection Market Outlook, Dental Procedures (2021-2030) ($MN)
23 Global Bupivacaine Hydrochloride Injection Market Outlook, Other Applications (2021-2030) ($MN)
24 Global Bupivacaine Hydrochloride Injection Market Outlook, End User (2021-2030) ($MN)
25 Global Bupivacaine Hydrochloride Injection Market Outlook, Ambulatory Surgical Centers (ASCs) (2021-2030) ($MN)
26 Global Bupivacaine Hydrochloride Injection Market Outlook, Hospitals & Clinics (2021-2030) ($MN)
27 Global Bupivacaine Hydrochloride Injection Market Outlook, Specialty Clinics & Pain Management Centers (2021-2030) ($MN)
28 Global Bupivacaine Hydrochloride Injection Market Outlook, Dental Clinics (2021-2030) ($MN)
29 Global Bupivacaine Hydrochloride Injection Market Outlook, Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.